Tumor tissues generated from the same genetic background as a particular mouse strain are referred to as syngeneic mouse models or allograft mouse tumor systems. Syngeneic models
are very useful for immuno-oncology research because they allow the investigation of tumor-immune system interactions in response to therapy. They make it possible to use the knowledge gained from in vitro screening and tests to the next level in vivo and get pharmacological or in vivo efficacy data.
Antineo provides a range of liquid tumors in syngeneic models, including models for leukemia, myeloma, and lymphoma.